Haim M. Barr

Rehovot, M 76100, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Linking biochemical and cellular efficacy of MERS coronavirus main protease inhibitors.

Linking biochemical and cellular efficacy of MERS coronavirus main protease inhibitors.

Journal: ACS pharmacology & translational science

Published: July 09, 2026

Linking biochemical and cellular efficacy of MERS coronavirus main protease inhibitors.

Linking biochemical and cellular efficacy of MERS coronavirus main protease inhibitors.

Journal: bioRxiv : the preprint server for biology

Published: February 27, 2026

Linking biochemical and cellular efficacy of MERS coronavirus main protease inhibitors.

Linking biochemical and cellular efficacy of MERS coronavirus main protease inhibitors.

Journal: bioRxiv : the preprint server for biology

Published: February 27, 2026

A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data.

A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data.

Journal: Journal of chemical information and modeling

Published: February 26, 2026

An exhaustive cell-based screen coupled with an intracellular-induced lux-based reporter identified bioactive molecules that inhibit host cell infection by intracellular pathogens.

An exhaustive cell-based screen coupled with an intracellular-induced lux-based reporter identified bioactive molecules that inhibit host cell infection by intracellular pathogens.

Journal: Frontiers in cellular and infection microbiology

Published: December 18, 2025

Antiferroptotic Drugs Reduce sFlt-1 Release and Placenta Damage in Preeclampsia.

Antiferroptotic Drugs Reduce sFlt-1 Release and Placenta Damage in Preeclampsia.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: August 19, 2025

A Structure-Based Computational Pipeline for Broad-Spectrum Antiviral Discovery.

A Structure-Based Computational Pipeline for Broad-Spectrum Antiviral Discovery.

Journal: bioRxiv : the preprint server for biology

Published: August 06, 2025

Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 protease.

Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 protease.

Journal: bioRxiv : the preprint server for biology

Published: July 16, 2025

Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor.

Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor.

Journal: bioRxiv : the preprint server for biology

Published: July 16, 2025

A pharmacological modality to sequester homomeric proteins.

A pharmacological modality to sequester homomeric proteins.

Journal: Nature chemical biology

Published: March 07, 2025

Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors.

Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors.

Journal: Research square

Published: February 24, 2025

Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors.

Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors.

Journal: Nature communications

Published: January 21, 2025

Showing 1-12 of 44

Last Updated: 09/26/2026